drug development companies
Companies whose enriched business profile is tagged “drug development”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + market data, shown with its as-of date.
- Neurocrine Biosciences (NBIX) Health Care — A neuroscience-focused biopharmaceutical company commercializing specialized treatments for neurological and endocrine disorders while advancing a diverse pipeline of therapeutic modalities. ask →
- CYTOKINETICS INC (CYTK) Health Care — A clinical-stage biopharmaceutical firm pioneering muscle-directed therapies for cardiovascular and neuromuscular diseases. ask →
- ERASCA INC (ERAS) Health Care — Erasca is a precision oncology company dedicated to shutting down the RAS/MAPK pathway to effectively treat patients with cancer. ask →
- DIANTHUS THERAPEUTICS INC (DNTH) Health Care — Dianthus Therapeutics is a clinical-stage biotechnology firm developing antibody-based complement inhibitors to treat severe autoimmune disorders. ask →
- Viking Therapeutics (VKTX) Health Care — A clinical-stage biopharmaceutical company developing next-generation dual GLP-1/GIP receptor agonists for the treatment of obesity and metabolic disorders. ask →
- TARSUS PHARMACEUTICALS INC (TARS) Health Care — Tarsus Pharmaceuticals is an ophthalmology-focused biopharmaceutical company best known for XDEMVY, a treatment for Demodex blepharitis. ask →
- ATAIBECKLEY INC (ATAI) Health Care — Atai Beckley is a clinical-stage biotech firm developing novel treatments for central nervous system disorders. ask →
- INHIBRX BIOSCIENCES INC (INBX) Health Care — Inhibrx Biosciences is a clinical-stage biotechnology company leveraging advanced protein engineering to develop targeted therapeutic candidates for complex diseases. ask →
- IMMIX BIOPHARMA INC (IMMX) Health Care — Immix Biopharma is a clinical-stage biopharmaceutical company developing novel therapeutic candidates to address critical unmet needs in oncology and inflammatory disease treatment. ask →
- Equillium, Inc. (EQ) Health Care — Equillium is a clinical-stage biotech developer of novel small-molecule and peptide therapeutics aimed at severe autoimmune and inflammatory diseases. ask →
- Aldeyra Therapeutics, Inc. (ALDX) Health Care — Biotechnology company developing novel RASP-modulating therapies to treat immune-mediated inflammatory diseases, with a lead focus on ocular health. ask →
Not quite it? Describe exactly what you want →
Frequently asked
What are the largest drug development companies?
By market capitalization, the largest drug development companies in the catalog include Neurocrine Biosciences (NBIX), CYTOKINETICS INC (CYTK), ERASCA INC (ERAS), DIANTHUS THERAPEUTICS INC (DNTH), Viking Therapeutics (VKTX).
How many drug development companies does stocks-llm track?
stocks-llm currently lists 11 drug development companies (as of 2026-10-08), each with dated fundamentals from SEC EDGAR and market data. Informational only — not financial advice.
Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Figures shown with their as-of date.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.